Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03499899
Brief Title: A Study of Efficacy and Safety of LAG525 in Combination With Spartalizumab, or With Spartalizumab and Carboplatin, or With Carboplatin, in Patients With Advanced Triple-negative Breast Cancer

First Submitted : March 26, 2018
First Submitted that Met QC Criteria : April 9, 2018
First Posted : April 17, 2018

Last Update Submitted that Met QC Criteria : July 17, 2019
Last Update Posted : July 19, 2019 (Estimate)